Key result
Factor-supported ultrasound-guided pericardiocentesis successfully resolves spontaneous cardiac tamponade in severe hemophilia A.
Why the study?
Hemophilia A is an X-linked recessive bleeding disorder characterized by factor VIII deficiency in which hemorrhage can be life-threatening when major organ systems are involved.
Case Report (n=1)
No
This case report demonstrates that spontaneous hemorrhagic cardiac tamponade in a patient with severe hemophilia A and factor VIII inhibitors can be rapidly diagnosed with bedside point-of-care ultrasound and safely treated with ultrasound-guided pericardiocentesis following hemostatic support with recombinant factor VIIa, fresh frozen plasma, and emicizumab.
Supports factor-supported pericardiocentesis for tamponade in pediatric hemophilia A; hypothesis-generating pending larger studies.
Introduction: Hemophilia A is an X-linked recessive bleeding disorder characterized by deficiency of factor VIII. The clinical features of this disease are hemorrhage and can be life-threatening when major organ systems are involved. Case Report: We report the case of a 13-year-old boy with severe hemophilia A and factor VIII inhibitors who presented with fever and septic arthritis, later developing refractory shock with tachyarrhythmia. Despite initial suspicion of sepsis-related myocarditis, point-of-care ultrasound (POCUS) revealed massive hemorrhagic pericardial effusion with tamponade physiology. Recombinant factor VIIa was transfused as hemostatic rescue therapy; the patient was subsequently started on fresh frozen plasma and emicizumab. Ultrasound-guided pericardiocentesis resulted in rapid hemodynamic recovery. Conclusion: This case highlights the importance of considering obstructive shock in unstable hemophilia patients and demonstrates that timely POCUS-based diagnosis and factor-supported pericardiocentesis can be lifesaving.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) conducted a case report in Severe hemophilia A with factor VIII inhibitors complicated by spontaneous hemorrhagic pericardial effusion and cardiac tamponade (n=1). Ultrasound-guided pericardiocentesis with recombinant factor VIIa, emicizumab, and fresh frozen plasma was evaluated on Resolution of cardiac tamponade and hemodynamic recovery. Factor-supported ultrasound-guided pericardiocentesis drained 900 mL of blood on day 1 and resolved spontaneous cardiac tamponade in a 13-year-old boy with severe hemophilia A and FVIII inhibitors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: